Crossmark

Predictors of treatment failure, time to switch and reasons for switching to second line antiretroviral therapy in HIV infected children receiving first line anti-retroviral therapy at a Tertiary Care Hospital in Ethiopia

Crossref DOI link: https://doi.org/10.1186/s12887-019-1402-1

Published Online: 2019-01-29

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Haile, Gelila Solomon

Berha, Alemseged Beyene http://orcid.org/0000-0003-3825-2863
License Information

Text and Data Mining valid from 2019-01-29
More Information

Article History

Received: 17 August 2018

Accepted: 14 January 2019

First Online: 29 January 2019

Ethics approval and consent to participate

: The study was done after the letter of ethical approval with a reference number of ERB/SOP/18/10/2018 was obtained from ethical review roard of School of Pharmacy, Addis Ababa University. All of the children at the HIV clinic who had been started on first line ART drugs based on the Ethiopia national guideline were included. Waiver of consent letter for this retrospective chart review was obtained from the Department of Pediatric and Child Health of TASH with a letter reference number: PD/SOM/206/10 to review patients’ charts for data collection. Privacy and confidentiality was strictly maintained throughout the whole process.

: Not applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below